SKI Market

A+| A| A-|

Indian Indices

Sensex

71,947.55 -1,635.67
( -2.22%)

Global Indices

Nasdaq

45,242.12 54.47
(0.12%)

Dow Jones

6,365.58 -24.27
(-0.38%)

Hang Seng

51,264.29 -621.56
(-1.20%)

Nikkei 225

10,127.96 160.61
(1.61%)

Forex

USD-INR

94.53 0.44
(0.47%)

EUR-INR

108.77 0.13
(0.12%)

GBP-INR

125.32 -0.25
(-0.20%)

JPY-INR

0.59 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Onyx Biotec Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

93585

INE0WVU01018

30.6759797

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ONYX

14.59

61.65

EPS(TTM)

Face Value()

Div & Yield %

2.33

Back

IDBI Bank consolidated net profit rises 73.56% in the September 2025 quarter

Oct 18,2025

Net profit of IDBI Bank rose 73.56% to Rs 3229.58 crore in the quarter ended September 2025 as against Rs 1860.80 crore during the previous quarter ended September 2024. Total Operating Income declined 4.51% to Rs 7109.01 crore in the quarter ended September 2025 as against Rs 7445.01 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Total Operating Income	7109.01	7445.01	-5
OPM %	76.78	62.65	-
PBDT	3796.59	2469.87	54
PBT	3796.59	2469.87	54
NP	3229.58	1860.80	74

71,947.55 -1,635.67 ( -2.22%)

45,242.12 54.47 (0.12%)

6,365.58 -24.27 (-0.38%)

51,264.29 -621.56 (-1.20%)

10,127.96 160.61 (1.61%)

94.53 0.44 (0.47%)

108.77 0.13 (0.12%)

125.32 -0.25 (-0.20%)

0.59 0.00 (-0.02%)